The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium
- PMID: 223706
- PMCID: PMC2043590
- DOI: 10.1111/j.1476-5381.1979.tb13690.x
The relationship between the pharmacokinetics, cholinesterase inhibition and facilitation of twitch tension of the quaternary ammonium anticholinesterase drugs, neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethylammonium
Abstract
1 The relationship between the concentration of drug in plasma, the inhibition of erythrocyte acetylcholinesterase and the facilitation of neuromuscular transmission has been studied in the rat after the administration of neostigmine, pyridostigmine, edrophonium and 3-hydroxyphenyltrimethyl-ammonium (3-OH PTMA). 2 After the administration of neostigmine or pyridostigmine, acetylcholinesterase activity recovered only slowly due to the covalent nature of the inhibition. In contrast, recovery from the reversible inhibition caused by edrophonium or 3-OH PTMA was rapid and showed a direct relationship to the plasma concentration of these drugs. 3 There was a statistically significant linear correlation between the logarithm of the plasma concentration of the drugs and the increase in the tibialis twitch tension. 4 The relationship between the inhibition of acetylcholinesterase and the facilitation of neuromuscular transmission was complex. When the enzyme was less than 85% inhibited no facilitation occurred. Between 85% and 98% inhibition, facilitation was linearly related to enzyme inhibition. Above 98% inhibition, facilitation was unrelated to inhibition of the enzyme.
Similar articles
-
Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.Anesthesiology. 1984 Nov;61(5):534-9. doi: 10.1097/00000542-198411000-00010. Anesthesiology. 1984. PMID: 6149707
-
The effect of edrophonium on erythrocyte acetylcholinesterase and neuromuscular function in the rat.Br J Pharmacol. 1976 Jan;56(1):93-9. doi: 10.1111/j.1476-5381.1976.tb06963.x. Br J Pharmacol. 1976. PMID: 175874 Free PMC article.
-
Twitch depression and train-of-four ratio after antagonism of pancuronium with edrophonium, neostigmine, or pyridostigmine.Anesth Analg. 1983 Mar;62(3):314-6. Anesth Analg. 1983. PMID: 6299135
-
Clinical pharmacokinetics of cholinesterase inhibitors.Clin Pharmacokinet. 1986 May-Jun;11(3):236-49. doi: 10.2165/00003088-198611030-00005. Clin Pharmacokinet. 1986. PMID: 3524957 Review.
-
Reversal of neuromuscular blockade.Anesthesiology. 1992 Oct;77(4):785-805. doi: 10.1097/00000542-199210000-00025. Anesthesiology. 1992. PMID: 1416176 Review. No abstract available.
Cited by
-
Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.Can J Anaesth. 1991 Sep;38(6):722-7. doi: 10.1007/BF03008449. Can J Anaesth. 1991. PMID: 1655299 Clinical Trial.
-
Priming with anti-cholinesterases--the effect of different combinations of anti-cholinesterases and different priming intervals.Can J Anaesth. 1988 Jan;35(1):47-52. doi: 10.1007/BF03010544. Can J Anaesth. 1988. PMID: 3349554 Clinical Trial.
-
Pyridostigmine in Pediatric Intestinal Pseudo-obstruction: Case Report of a 2-year Old Girl and Literature Review.J Neurogastroenterol Motil. 2019 Oct 30;25(4):508-514. doi: 10.5056/jnm19078. J Neurogastroenterol Motil. 2019. PMID: 31587541 Free PMC article. Review.
-
Accelerated reversal of atracurium blockade with divided doses of neostigmine.Can Anaesth Soc J. 1986 Nov;33(6):723-8. doi: 10.1007/BF03027121. Can Anaesth Soc J. 1986. PMID: 3779494
-
Accelerated reversal of pancuronium blockade with divided administration of neostigmine.J Anesth. 1989 Sep 1;3(2):240-3. doi: 10.1007/s0054090030240. J Anesth. 1989. PMID: 15236047 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources